Mathematical and Experimental Models for HIV Dynamics
Project Number5R01AI055343-05
Contact PI/Project LeaderHOLTE, SARAH E
Awardee OrganizationFRED HUTCHINSON CANCER RESEARCH CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): The research in this proposal focuses on using mathematical and statistical models to answer questions about factors that affect the dynamics of HIV infection using both experimental and clinical data. The proposed research consists of interdisciplinary interactions between quantitative and biological scientists and will guide the development and analysis of the mathematical models. Conversely, model outcomes will direct further experiments and data collection. Our investigations are based on systems of ordinary and partial differential equations and will require sophisticated mathematical and statistical analysis. The need for sound statistical methods is inherent in the development of models for laboratory and clinical data. Rigorous computational and stochastic methods for nonlinear random effects statistical models will be applied to a variety of data from aggregate populations of individuals. At present, standard techniques are only partially adequate due to the extreme computational costs of existing methods. To overcome this difficulty, a new "integrated data" method for parameter estimation and inference in nonlinear random effects models will be developed. Specific experimental and clinical research will include investigating the effects of competition between various strains of HIV in laboratory experiments and analysis of clinical data that will reveal the nature of nonlinear decay characteristics of populations of HIV-infected cells. The in vitro study will be designed based on mathematical models to assess the effects of the target-cell population size on the dynamics of two strains of HIV Laboratory experiments will guide and be guided by mathematical models and be conducted based on a recently developed culture system that allows control over the infected cell death rate so that the experiments can be conducted in a setting more similar to the in vivo condition. The in vivo clinical analysis will characterize the decay behavior for populations of HIV-1 infected cells following HAART. Previous predictions---based on linear models---of the time needed for viral eradication from an infected individual have not been realized in clinical observations. Furthermore, future treatment and management of HIV infected individuals relies heavily on an accurate understanding of the decay characteristics of infected cell populations. Thus there is an urgent need to more accurately describe the decay profile of infected cell populations.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
078200995
UEI
HMSNCM57QNR5
Project Start Date
01-April-2003
Project End Date
31-December-2009
Budget Start Date
01-April-2007
Budget End Date
31-December-2009
Project Funding Information for 2007
Total Funding
$328,070
Direct Costs
$189,636
Indirect Costs
$138,434
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Allergy and Infectious Diseases
$328,070
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI055343-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI055343-05
Patents
No Patents information available for 5R01AI055343-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI055343-05
Clinical Studies
No Clinical Studies information available for 5R01AI055343-05
News and More
Related News Releases
No news release information available for 5R01AI055343-05
History
No Historical information available for 5R01AI055343-05
Similar Projects
No Similar Projects information available for 5R01AI055343-05